Literature DB >> 6390085

Removal of T cells from bone marrow for transplantation. Comparison of rat monoclonal anti-lymphocyte antibodies of different isotypes.

G Hale, T Hoang, T Prospero, S M Watt, H Waldmann.   

Abstract

We describe a family of six rat monoclonal antibodies which appear to recognize identical or closely related determinants present on virtually all mature human lymphocytes and monocytes, but absent from other blood cells including myeloid and erythroid colony-forming cells. Four IgM antibodies and one IgG2a fix human complement; one IgG2c antibody does so only poorly. All of the antibodies react with lymphocytes from baboons, rhesus and cynomolgus monkeys. However, in all baboons and rhesus monkeys tested, and some cynomolgus monkeys, they also recognize red cells. Nevertheless, in other cynomolgus monkeys reactivity is with lymphocytes only, so these animals will be suitable models for testing the effects of the antibodies in vivo. The antibodies described here could be useful for in vitro removal of lymphocytes from allogeneic marrow grafts (to prevent graft-versus-host disease) or malignant lymphoid cells from autologous grafts (for treatment of leukaemia) and may also find application as general immunosuppressants and for immunotherapy of leukaemia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6390085

Source DB:  PubMed          Journal:  Mol Biol Med        ISSN: 0735-1313


  6 in total

1.  Nonmyeloablative conditioning regimen to increase engraftment of gene-modified hematopoietic stem cells in young rhesus monkeys.

Authors:  Alice F Tarantal; Francesca Giannoni; C Chang I Lee; Jennifer Wherley; Teiko Sumiyoshi; Michele Martinez; Christoph A Kahl; David Elashoff; Stan G Louie; Donald B Kohn
Journal:  Mol Ther       Date:  2012-01-31       Impact factor: 11.454

2.  Buzz around Campath proof-of-concept trial in MS.

Authors:  Randy Osborne
Journal:  Nat Biotechnol       Date:  2009-01       Impact factor: 54.908

3.  Reshaping a therapeutic CD4 antibody.

Authors:  S D Gorman; M R Clark; E G Routledge; S P Cobbold; H Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

4.  Post-transplant repopulation of naïve and memory T cells in blood and lymphoid tissue after alemtuzumab-mediated depletion in heart-transplanted cynomolgus monkeys.

Authors:  M R L Marco; E M Dons; D J van der Windt; J K Bhama; L T Lu; A F Zahorchak; F G Lakkis; D K C Cooper; M B Ezzelarab; A W Thomson
Journal:  Transpl Immunol       Date:  2013-10-09       Impact factor: 1.708

5.  Immunohistochemical analysis of CDw52 antigen expression in non-Hodgkin's lymphomas.

Authors:  J R Salisbury; N T Rapson; J D Codd; M V Rogers; A B Nethersell
Journal:  J Clin Pathol       Date:  1994-04       Impact factor: 3.411

Review 6.  Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders.

Authors:  G A Pangalis; M N Dimopoulou; M K Angelopoulou; C Tsekouras; T P Vassilakopoulos; G Vaiopoulos; M P Siakantaris
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.